chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have previously been a pretty healthy person. Just shy of four months after receiving the COVID vaccination, I was diagnosed with Hashimotos thyroid disease as well as tachycardia heart issues. I had blood testing complete four months prior to receiving the vaccination showing that my thyroid levels were within the normal range.  My quality of life has significantly decreased over the last few months. I went from being both a physically active (health conscious bodybuilder) and mentally active (executive assistant to CEO's) person to feeling just awful most days. I think it should be looked into as to whether or not the vaccine is causing some people to develop thyroid and heart disease and if it can be avoided.
Mother called at 415 states her daughter is having a reaction from Tdap & what can she do. Spoke to daughter & states she woke up at night, sweating, at 745 severe headache, hurts to breathe & difficulty bending & walking. Called Mom back at 450 pt was asleep. Instructed to see a doctor if sx gets worse. 9/2/11 920 pt doing well.
Arthritis in knees; Flu symptoms; Throwing up; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Arthritis in knees), INFLUENZA (Flu symptoms) and VOMITING (Throwing up) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) UNK, CF. On an unknown date, the patient experienced ARTHRITIS (Arthritis in knees), INFLUENZA (Flu symptoms) and VOMITING (Throwing up). At the time of the report, ARTHRITIS (Arthritis in knees) was resolving and INFLUENZA (Flu symptoms) and VOMITING (Throwing up) had resolved.            Concomitant medication was not provided.  Treatment medication information was not provided by the reporter.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.   This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.; Sender's Comments: Company comment: This is a spontaneous case concerning an adult female patient with Chron´s disease on treatment with Adalimumab, who experienced the serious (medically significant) unexpected event arthritis in knees, on an unknown date after the second dose of mRNA-1273. Clinical course, diagnostic tests and treatment details were not provided. Adalimumab was reported as a co-suspect product. Events was reported as non serious and upgraded seriousness as per RA list. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Inflammation swelling, sensibility of breasts (both); swelling, sensibility of breasts (both); sensibility of breasts (both); found lumps; Psychological fear; This is a spontaneous report from a contactable consumer(patient). A 36-years-old non pregnant female patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number:EWO161), via an unspecified route of administration, administered in right arm on 28May2021 13:00 (at the age of 36 years old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included resin allergy and covid-19. Concomitant medications included spirulina [spirulina spp.] (SPIRULINA), camellia sinensis extract (GREEN TEA). The patient previously took cefadroxil and experienced drug hypersensitivity. The patient was not pregnant at time of vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had covid prior vaccination and has not been covid tested post vaccination. On 31May2021, patient experienced inflammation, swelling, sensibility of breasts (both). patient was checked by obstetrician-gynecologist, who found lumps, then patient got a mammogram and ultrasound and it looks normal for now not cancer. After the vaccine patient had to go into all these check ups and costly procedures and the psychological fear that accompanied them is also a cause of huge concern for patient. Patient has received treatment for the adverse event. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
As of 12/28/2020 patient stated that when pressed her right arm feels tender. She also has been having limited range of motion for the arm in the way that she has difficulty reaching behind the back. Patient also complained of having difficulty laying on the right side due to pain.
Patient received flu vaccination in left arm.  Patient says she started to get a red knot the size of a baseball , hot and itching.  She didn't experience problems until day after flu shot.  She didn't seek medical attention, she called the Director and called healthcare center. We advised her to contact the physician if further problems.
Patient reported itching, shortness of breath and tightening of the throat post vaccine administration.  50mg Benadryl was given.  Patient reported and had no other issues during dialysis treatment.  Patient left the clinic ambulatory with no complaints.
Initial report receive on 27 November 2006 from a healthcare professional in USA. A 22 year old female patient received on 22 November 2006, first dose of Imovax (lot number 20905-2), intramuscular into the left arm. The patient, an anmimal worker received Imovax as pre exposure series.  On 23 November 2006, a day post vaccination, the patient developed itchy rash over her chest and also numbness. The patient was treated with Benadryl. The events resolved within 3 days and the patient recovered. The patient's medical history was not reported. Concomitant vaccines were not reported. Follow up information received on 11 January 2007. The patient received the vaccine in the morning of 22 Novermber 2006 and the onset of symptoms was in the morning of 23 November 2006. She experienced numbness and an itchy rash on her anterior chest wall. She did not have any medical history. At the time of the vaccination, she was not on any medications nor did she have any illness. She did not have any other immunization within 4 weeks of receiveing Imovax. She did not complete the series of rabies vaccinations.
Severe brain fog, dizziness, fatigue, nausea, diarrhea, sore arm, headache
I contracted COVID-19 on 06/23/2022 with symptoms of scratch throat, headache, body aches, fever of 100, diarrhea, shortness of breathe, loss of hearing in right ear for one day, and fatigue. I was prescribed an antiviral, but did not take it due to learning of the vast amount of rebound infections. I was ill for 10 days before my symptoms began to resolve. I am fully recovered with no lingering symptoms.
Itching began on 9/9 & on 9/23 she went to the ER for IV benadryl, oral predisone. Patient reports she is beginning to feel better.
Patient sitting in chair, alert and oriented x 3, skin color was ashen. Patient felt strange over her chest, light headed, patient said she feels like she was going to pass out immediately after vaccine administration.  VS 100/60 mmHg, pulse 64, RR 22.  Patient complaints of headache, nausea and skin clamy and warm. Site manager made aware, o2 @ 2 L via nasal cannula administered.  EMS transport to hospital.  Daughter was made aware via VM, unable to reach 3x attempts.
Patient states the adverse reaction started on the next day and told me that she had: ultra sensitive skin, fever, chills, headache, muscle pain, slept for 24 hours straight.
Received "Moderna COVID-19 Vaccine EUA" Red, swollen, orange-peel like skin,  itchy patch on same arm as the vaccine injection site.  Patch is 4 inches x 4 inches round, located just below the vaccine injection site.  Continues through the day, redness intensifying thru the day, itch remains same as the early morning when first observed.
no adverse effect reported; one patient received on dose of MMR II (R036582 12/17/2020) reconstituted with expired DILUENT (N026990 9/26/2018). All products stored properly with no temperature excursions.; This spontaneous report was received from a office manager, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 01-JUL-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live rHA (recombinant Human albumin) (M-M-R II) lot # R036582, expiration date reported as 17-DEC-2020, for prophylaxis (strength, dose, route and frequency were not reported) that was reconstituted with an expired sterile diluent(MERCK STERILE DILUENT) lot # N026990, expiration date reported as 26-SEP-2018 (strength, dose, route, frequency and indication were not reported). No adverse effect reported.  This is one of three reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA011374:01273448
Went to ER because eyes swelled shut several hours after shot. Gave BENADRYL, checked BP - was very high. Patient reports kidney damage - now has 50% function.
ARM SHORNESS; CALLER IS NOT SURE IF HE RECEIVED FULL SHOT; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced possible incorrect dose administered, and arm shorness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arm shorness and possible incorrect dose administered was not reported. This report was non-serious.
Within a few days of receiving the vaccine she suffered what was diagnosed as an atypical migraine with stroke like symptoms of numbness of arm, face, tongue. She recovered and she has not had another migraine that presented with the numbness since. However, she has continued to have regular headaches and migraines since then.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On an unknown date the patient was administered with GARDASIL 9 (strength, dose, route and lot number unspecified), which underwent a supported temperature excursion. No adverse effects were reported. This is one of the 23 reports received from the same reporter. Additional information has been requested.
COVID+ 11/5/22.  Vaccination status - Moderna x3, + pfizer bivalent x1       BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 11/4/2022 Discharge Date: 11/07/2022    Active Hospital Problems   Diagnosis Date Noted POA ? Community acquired pneumonia, bilateral 11/05/2022 No     DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Community acquired pneumonia, unspecified laterality [J18.9] Community acquired pneumonia, bilateral [J18.9]   HOSPITAL COURSE: Patient is a 87 y.o. female with a past medical history of hypertension, GERD, hypothyroidism, CVA and lupus, who presents today with altered mental status.  She was recently hospitalized for acute CVA 9/11-9/14.  Patient was discharged on 9/30 to assisted living facility. She just came back to her son's house a week ago. Patient was notified that there was several COVID cases the living facility where she stayed.  Last week, patient developed productive cough, rhinorrhea, sinus congestion, nausea, lethargy, sleepiness. Patient reported diarrhea this Wednesday, but she was taking prunes for her constipation.  Coming in today, there are concerns about altered mental status, shortness of breath, and chills. EMS gave 1L fluid. Patient's mental status significantly improved on arrival at the ED.  chest x-ray was performed concerning for pneumonia.  Patient had a positive COVID test.  It also was found that patient had elevated procal and leukocytosis, for which she was covered for community-acquired pneumonia with Rocephin and Zithromax.  She was also started on remdesivir.  A repeat urinalysis came back concerning and urine culture were obtained. Patient was discharged with 2 days left of antibiotics.  Pt with ED visit at Hospital on 11/9/22 with   CHIEF COMPLAINT: LOW BLOOD PRESSURE Assessment/Plan  DIAGNOSIS at time of disposition: 1. Weakness  MEDICAL DECISION MAKING: 87-year-old female with recent COVID-19/pneumonia hospitalization presents to the emergency department with global weakness that has been worsening now only since recent hospitalization but about over the past year.  Awake and alert, slightly slow on exam.  She is bradycardic with normal blood pressure in the emergency department.  On repeat exam, she seems slightly more awake after IV fluids.  Labs are largely reassuring with signs of mild dehydration.  I spoke to the patient and her son at length both about her disposition and potential medication changes.  The patient is on Toprol and clonidine.  I recommended decreasing both of these medications with early outpatient follow-up.  The patient's son was comfortable taking her home, I encouraged her to eat and drink more at home.  I do feel that the patient is likely suffering from side effects of over medication.  She was discharged home in stable condition for early outpatient follow-up.
5 days after MMR, varicella, and hepatitis A vaccines patient developed cough, wheezing, and fever.  Mom attributes these symptoms to the vaccine and requested they be reported.
Patient received Pfizer COVID vaccine on December 22nd.  Unknown to clinic patient signed up and received Moderna vaccine.  Patient is physician and was aware he was receiving a different vaccine.
WOKE UP ON MORNING OF 23RD WITH FEVER, "BURNING SENSATION" REDNESS AND INDURATION 1/2" FROM SITE.  SHE TOOK IBUPROFEN 800 MG, APPLIED ICE TO SITE, REPORTS RESOLVED AFTER 24 HRS.
patient developed syncope after receiving vaccine, assist patient to medical bay. Vital Signs monitored, elevated feet. Offered Water. Patient stable, release from vaccination site.
This spontaneous report as received from a Doctor of pharmacy refers to a 34 year old patient. On 12-SEP-2013, the patient was vaccinated with a 0.5 ml dose of PNEUMOVAX23 (Lot # H022280, expiration date 16-JUL-2014), intramuscularly. The pharmacist reported that on 12-SEP-2013, the patient noticed that the injection site was red, swollen, painful to touch and a slight fever ha developed. The patient did not receive treatment for the adverse events. There were no lab diagnostics or studies performed. At the time of the report, the patient was recovering. This is one of several reports received from the same source. Additional information has been requested.
Symptoms:  Starting at about 10pm on day of injection, worsening throughout the night and morning, and largely subsiding by 5pm the day after. Fever, sleeplessness, fatigue, dizziness, slowed mental capacity, joint pain in arms, legs, neck, and back. Pain in arm at site of injection. Nausea when eating.  Treatment: 400 mg ibuprofen on day after at 3:30pm  Outcomes: Symptoms began to significantly start subsiding at 4pm the day after injection.
On 4-9-2021, pt (community member) came in to receive a covid vaccine.    Pt answered health questionnaire and was unremarkable, thus vaccine was given after all consents were signed and identity was confirmed with 2 sources. Pt arm was prepared as per policy and procedure. Pt asked, "are you a nurse and what method of vaccination are you going to use?" I told the patient that I am a nurse and that I was going to use the z track method to administer vaccine and then described it. After cleaning the site the patient stated, "wait let it dry and began wafting the site."  The patient was told not to do this as waving air toward the site would bring germs to it. The patient's deltoid was then prepared again. The vaccine was administered as per policy and procedure.  About 10 minutes after receiving vaccine pt stated she was having eye discomfort but denied other symptoms. The patient was offered oral Benadryl as an anaphylactic response was not apparent. The patient refused the clinic's Benadryl and stated I have my own. The patient was given water and took 25mg of Benadryl by mouth. The patient was also asked to stay 15 to 30 minutes longer for observation as it appeared she was having a mild reaction. Patient was agreeable. Blood pressure was 178/80, heart rate was 78, and oxygen saturation was 95 on room air with a respiratory rate of 18. No signs or symptoms of distress were noted. At 11:00, patient was asked if she felt better. The patient stated yes, but stated having numbness in arm that vaccine was given in. The arm was assessed, patient was able to move arm in full range of motion, capillary refill was less than 3 seconds, and no swelling or redness was observed. The patient then stated, "oh it just must be my muscle."  The patient was educated that a sore arm was to be expected and was a common side effect, but if the numbness worsened or diminished function was observed she should go to the Emergency Room. Pt stated understanding. The patient stated, that at this times she needed to go because her daughter had to go to work. The patient was encouraged to stay for more observation, but refused and stated she was feeling better. The patient was told to go to the emergency room if symptoms worsened. Patient was also educated on her blood pressure, as it was noted to be elevated. The patient stated she took her blood pressure medications that morning. The patient was asked to take blood pressure at least 2 more times ( at lunch and dinner time) and if blood pressure remained higher than 170 systolic (on the top number), that she needed to go to the emergency room and consult with her primary doctor. Patient stated understanding. Clinic phone number was provided to patient, in case she had any question or concerns. Patient was able to exit clinic with a steady gain, alert and oriented x3, and with no signs or symptoms of distress noted
Large (about 3 inches across) redness, tightness, swelling, hot at injection site Chills Headache Body pain  Sluggishness
Pt was checking out at the front desk. Pt had received a tb skin test and flu vaccine, pt was noticed turning pale and off balance. Pt then fell to the ground, writer witnessed the fall. Pt was unconscious for 20 seconds and came to. Pt skin cool, pale and clammy. bp stable 98/62, pulse 86 and resp 18. Cool wash cloth placed on forehead. Pt stated she was not dizzy and felt ok. She was then sat up on the floor. Staff assisted with getting pt into wheelchair and brought back to room for pt to be rechecked out by PCP. Pt was given water and apple juice. Pt stated she felt much better. She states she had never passed out prior and she did not eat anything this am prior to the appointment. Advised to eat lunch
possible apneic episode on 11JUN98 @ daycare;negative work up in ER;
I had dizziness and a headache that jumped around my head within 20 minutes of the shot. About two hours in it felt like my tongue was increasingly getting heavier and heavier for around a 10 minutes timeframe.  It then stopped but for two days it felt like I had burnt my tastebuds. Starting two days ago I have developed a red rash on my arms that burns at times and seems to come and go.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 13-NOV-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J006831 and expiry date: 14-SEP-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
Guillain-barre syndrome; Inflammation at the injection site; Tingling and numbness now spread to her finger tips; Tingling and numbness now spread to her finger tips; This spontaneous report  was reported by a physician concerning a 49-years-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) and experienced Guillain-Barre syndrome, inflammation at the injection site and tingling and numbness now spread to her finger tips.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.    On 18 Mar 2021, prior to onset of the events, the patient received first of two planned doses of mRNA-1273 (lot/batch number: unknown) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.  On 18 Mar 2021, the patient experienced inflammation at the injection site, tingling and numbness now spread to her fingertips and might be developing medically significant event of Guillain-Barre syndrome. On 19 Mar 2021, increasing severity of tingling and numbness. Treatment for the events included ibuprofen.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events Guillain-Barre syndrome, inflammation at the injection site and tingling and numbness now spread to her finger tips was not reported.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Patient came in for her 2nd dose of Pfizer, verified everything on the consent form with the patient such as her dizziness and fainting after a vaccination.  I asked the patient how she did after the 1st dose and she said she was fine.  First shot patient had her fiance.  That day she was by herself and she was feeling very nervous about the second dose.  I asked her if she's ok and we can hold off on the vaccine and she said she's fine, she'll be ok.  Then after giving her the shot, she said she was feeling the shot and that she was feeling dizzy.  I advised the patient to stay seated and asked if she wanted any snack to help and she said yes.  I gave her some  cracker and  juice
Afebrile, 3x3 area around site, warm to touch, body aches.
Almost immediately after receiving pneumococcal vaccine IM patient complained of difficulty breathing. She appeared flushed, and had a slight cough. She also complained of feeling light headed. Before treatment could be administered, patient started to look better, color improved, and she stated she was breathing better. The pulse oximeter showed a Sp02 of 92% when first applied, it quickly went to 95-98%. No medication or oxygen was provided. Vitals signs and Sp02 was monitored for approximately 45 minutes, they remained stable. Her temp was 97.3. Patient was sent home in her parents care.
Freezing cold, 3 hours later sweating, headace, no abnornal temperature, slept 12 hours. Next day cold and calmy, headaces. napped 2 hour then awoke and felt better but very treid.
Felt like I had the flu during a 24 hour period starting about 18 hours after I had the second shot in the series
Upon administration of Engerix-B, entire dept devel flu-like sx & aches & pains; Events were not permanently disabling;
Redness under the site of injection a few inches away from injection site. It was red and warm to touch with a small blister. Possible skin infection.  She was referred to her PCP for follow-up to rule out a skin infection.